Because the quality of cost-effectiveness studies related to the Thai context is still limited, the Thai health technology assessment guidelines have been firstly developed in Thailand for researchers to stimulate the provision of standardized, reliable and good quality information which can be used by policy makers and healthcare personnel for mak

Veronika J Wirtz*, Hans V Hogerzeil*, Andrew L Gray*, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens,

Abstract A trend towards charging for access to research findings, tools and databases is becoming more prominent globally. But charging for the use of research tools and databases that are vital to research supporting national and international policy development might be unjustified. Financial

On 17th September 2018, Sarah Garner, coordinator of the Innovation, Access and Use team under the Essential Medicines and Health Products program, World Health Organization, had an informal meeting at the Health Intervention and Technology Assessment Program (HITAP). She was eager to learn about HI

A few years ago, my daughter sprained her ankle at dance camp. What happened next offers a glimpse into some of the problems in our nation’s health care system.For years, we’ve been hearing that the United States spends more on health care than any other country, even as it lags far behind other cou

RIVERSIDE, Calif. — In the Inland Empire, an economically depressed region in Southern California, President Obama’s health care law is expected to extend insurance coverage to more than 300,000 people by 2014. But coverage will not necessarily translate into care: Local health experts doubt there w

Project ConsultantSripen TantivessPattara LeelahavarongNetnapis Suchonwanich59002017R2021L4Drug procurement,price performance,public hospital,พระราชบัญญัติการจัดซื้อจัดจ้างและการบริหารพัสดุภาครัฐ

(Reuters) – Victims of thalidomide said on Saturday an apology from the German inventor of the drug that caused birth defects in thousands of babies around the world was too little too late.Thalidomide, developed by the German firm Gruenenthal, was marketed internationally to pregnant women in the l

(Reuters) – GlaxoSmithKline is holding talks this weekend with Human Genome Sciences to agree a deal to acquire it for some $2.6 billion, after pursuing the U.S. biotech company for three months, sources familiar with the situation said on Sunday.The British pharmaceutical giant could sweeten its pr

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the